TRILLIANT
27.11.2023 08:01:29 CET | Business Wire | Press release
Enlit Europe 2023 — Trilliant, a leading international provider of solutions for advanced metering infrastructure (AMI), smart grid, smart cities and IIoT, will participate in Enlit Europe as a Silver Partner. The conference will take place at Paris Expo Porte de Versailles in France from November 28-30, 2023.
Enlit Europe addresses every aspect of the energy agenda and welcomes 15,000 energy professionals, 700 exhibitors and 500 speakers. The conference provides a space for energy leaders, start-ups, scale-ups and entrepreneurs to learn about new technologies and new insights related to the energy transition.
“Enlit Europe is a critical opportunity for energy leaders to meet and learn from each other,” said Tom Tipple, Managing Director of EMEA for Trilliant. “We’re excited to participate at this year’s event, and we look forward to discussing digital strategies for our industry. In particular, Trilliant continues to focus on how we can provide true interoperability as the energy transition continues.”
During the event, Trilliant executives will participate in engaging sessions:
- As part of the Summit programme, on November 28 at 2 p.m. Sozon Kokkinaras, Director of Customer Operations, APAC at Trilliant, will participate alongside other industry experts, engaging in a moderated panel discussion titled “Digital Strategies.” The session will be followed by the opportunity for a Q&A, and will take place on the Inspire Stage (Hall 7.3).
- Additionally, Trilliant’s Gavin Farrand, VP of Sales, UK and Europe, will present a session focused on interoperability titled “Empowering Interoperability through an Independent Data Layer” for the Digitalisation Hub. This session will be held on November 28 at 2:15 p.m. in Theatre 2 (Hall 7.3).
See Trilliant’s Power of Choice Value Proposition in Action
Attendees can visit Trilliant at Stand 7.2.A140, where they can Discover the Power of Choice via demonstrations of the company’s Next-Generation Network Technologies, AMI, Demand Response, Data & Analytics, and a new AMI for Smart Water solution.
Trilliant works with utilities across the globe to digitalize their water networks with its Smart Water solution. Its ease and speed of installation, performance and scalability make it not only powerful, but also unique. It’s designed to work with virtually any system to provide a secure, powerful source of data.
The Smart Water solution is also key part of Trilliant’s smart building initiative. Trilliant is revolutionizing connectivity in buildings, while empowering building owners to better manage infrastructure without intrusive wired installations. Trilliant has successfully implemented water solutions in Canada, the United Kingdom, Chile, Dominican Republic, Peru, and Japan.
From residential to commercial developments, Trilliant’s solutions range from electrical and thermal applications to water, reducing or eliminating the overhead costs, risks, and maintenance that come with wired installations.
Trilliant also continues to work closely with utility companies around the world, supporting them to meet their energy transition goals. The company most recently announced an extension of its partnership with Tenaga Nasional Berhad (TNB), the largest utility in Malaysia, to accelerate TNB’s path to net zero. It also launched a new partnership with IntelliSmart Infrastructure Private Limited, a leading Advanced Metering Infrastructure Service Provider (AMISP) and digital solutions provider in India, supporting Head-end System (HES) cellular implementations.
To learn more about Trilliant’s solutions, or to book a one-on-one demo and meeting with Trilliant at Enlit Europe, contact info@trilliant.com.
For more information about Enlit Europe, visit: https://www.enlit-europe.com/
About Trilliant
Trilliant® empowers the global energy industry with the only device-agnostic communications platform that enables utilities and cities to deploy any application securely and reliably on one powerful network. Our purpose-built portfolio is designed to offer the power of choice, without risk of customers being “locked in” with one technology provider or meter manufacturer. We are proud to offer mission-critical solutions that support AMI, Data & Analytics, Smart Metering, Smart Grids and Smart Cities. Customers worldwide benefit from Trilliant’s unique combination of flexibility, sustainability and scalability that connects utilities and cities to the IIoT and a more strategic path to the Energy Transition. Visit us at www.trilliant.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231126337008/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom